Methazolamide
Back to searchMolecule Structure
Scientific Name
Methazolamide
Description of the Drug
Methazolamide is a carbonic anhydrase inhibitor used to treat open angle glaucoma and acute angle closure glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00703
http://www.drugbank.ca/drugs/DB00703
Brand Name(s)
Methazolamide, Neptazane
Company Owner(s)
Lederle Laboratories Div American Cyanamid Co, Athem Holdings Llc, Applied Analytical Industries, Sandoz Inc, Mikart Llc, Bausch And Lomb Inc, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbonic anhydrase IV | SINGLE PROTEIN | INHIBITOR | CHEMBL3729 |
| Carbonic anhydrase I | SINGLE PROTEIN | INHIBITOR | CHEMBL261 |
| Carbonic anhydrase VII | SINGLE PROTEIN | INHIBITOR | CHEMBL2326 |
| Carbonic anhydrase II | SINGLE PROTEIN | INHIBITOR | CHEMBL205 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24687 | |
| DrugBank | DB00703 | |
| PubChem: Thomson Pharma | 15220808 | |
| BindingDB | 50013792 | |
| Brenda | 165527 | |
| ChemicalBook | CB6150374 | |
| rxnorm | NEPTAZANE | METHAZOLAMIDE |
| KEGG Ligand | C07764 | |
| ChEBI | 6822 | |
| ZINC | ZINC000100019188 |
